Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michelle Belzile"'
Autor:
Najib Babul, Catherine M. Neumann, Eduardo Bruera, Michelle Belzile, Zoltan Harsanyi, Andrew C. Darke
Publikováno v:
Journal of Pain and Symptom Management. 19:427-435
To compare a novel controlled-release formulation of metoclopramide with placebo in patients with cancer-associated dyspepsia syndrome, 26 adult patients with a ⩾1 month history of cancer-associated dyspepsia syndrome were randomized to receive eit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd5535fbab55e8a4f22df31764e25af
https://doi.org/10.1016/s0885-3924(00)00138-x
https://doi.org/10.1016/s0885-3924(00)00138-x
Autor:
Andrew Darke, Zoltan Harsanyi, Catherine M. Neumann, Michelle Belzile, I. Ford, Eduardo Bruera
Publikováno v:
Supportive Care in Cancer. 7:280-283
We evaluated the safety and efficacy of controlled-release morphine sulphate suppositories administered 12-hourly and once daily in patients with chronic cancer in a randomized double-blind crossover trial. Pain was assessed using a 100-mm VAS pain s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83bb50d05d53a62e98925c7bda261e93
https://doi.org/10.1007/s005200050261
https://doi.org/10.1007/s005200050261
Autor:
Najib Babul, Iva Ford, Michelle Belzile, Edith Pituskin, Robin L. Fainsinger, Zoltan Harsanyi, Eduardo Bruera, Andrew Darke
Publikováno v:
Journal of Clinical Oncology. 16:3222-3229
PURPOSE Use of oxycodone for chronic cancer pain has been hampered by its short elimination half-life. This study was designed to compare the efficacy and safety of controlled-release formulations of oxycodone and morphine for cancer pain. PATIENTS A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462610d0ee0b8d11df104e0345c9f6df
https://doi.org/10.1200/jco.1998.16.10.3222
https://doi.org/10.1200/jco.1998.16.10.3222
Publikováno v:
Cancer. 78:852-857
BACKGROUND When a change of opioid is considered, equianalgesic dose tables are used. These tables generally propose a dose ratio of 5:1 between morphine and hydromorphone. In the case of a change from subcutaneous hydromorphone to methadone, dose ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973b11a4bcd233bf173ff1fc8d32562e
https://doi.org/10.1002/(sici)1097-0142(19960815)78:4<852::aid-cncr23>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19960815)78:4<852::aid-cncr23>3.0.co
Publikováno v:
Cancer Treatment Reviews. 22:131-136
The dose ratio, analgesic efficacy, toxicity and cost of methadone for cancer pain were evaluated in a retrospective review of 50 consecutive patients treated on a Palliative Care Unit. Patients were switched from hydromorphone 267.7 +/- 178.8 mg sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be069e0c52db1328fa4e4129fec6b22
https://doi.org/10.1016/s0305-7372(96)90075-4
https://doi.org/10.1016/s0305-7372(96)90075-4
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 15(2)
PURPOSE AND METHODS There is an ongoing debate about the legalization of euthanasia. The attitudes and beliefs of the general public and physicians appear to differ; the views of patients have not been adequately explored. During 1995, we conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc05dc4d01a5fb6f17549b2a92202ad
https://pubmed.ncbi.nlm.nih.gov/9053459
https://pubmed.ncbi.nlm.nih.gov/9053459
Publikováno v:
Journal of palliative care. 12(4)
We have previously published data on our use of opioids in the last week of life. A change in our pattern of opioid use, i.e. switching opioids more frequently and using high-dose methadone suppositories, appears to have resulted in a decrease in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3130e6efa331970f353e1821e286d27
https://pubmed.ncbi.nlm.nih.gov/9019031
https://pubmed.ncbi.nlm.nih.gov/9019031